Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: Tea polyphenol-derived nanomedicine for targeted photothermal thrombolysis and inflammation suppression

Fig. 5

Cell viability of (a) MOVAS, (b) RAW 264.7, and (c) HUVEC upon exposure to varying concentrations of TPNs, TPNs-PEG, TPNs/ICG-PEG, and TPNs/ICG-cRGD. (d) Fluorescence micrographs, (e-i) flow cytometry data and quantification of intensity illustrating the ability of TPNs/ICG-cRGD to scavenge different types of RONS in RAW264.7 cells with LPS pretreatment (n = 3). Scale bar = 100 μm

Back to article page